Literature DB >> 10333526

Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT).

M Wick1, D Zubov, G Hagen.   

Abstract

The enzyme telomerase plays a crucial role in cellular proliferation and tumorigenesis. By adding hexameric repeats to chromosome ends, it prevents telomeric loss and, thus, entry into senescence. Recent data suggest that expression of the human telomerase reverse transcriptase subunit (hTERT) represents the limiting factor for telomerase activity. To gain an insight into the mechanisms regulating hTERT expression, we have determined the complete genomic organization of the hTERT gene and isolated the 5'- and 3'- flanking region. The hTERT gene encompasses more than 37kb and consists of 16 exons. We show that all hTERT insertion and deletion variants described so far most likely result from the usage of alternative splice consensus sequences in intron or exon regions. Furthermore, we identified a new hTERT splice variant. Analysis of the DNA sequence surrounding the putative transcriptional start region revealed a TATA-less promoter located in a CpG island. A promoter fragment spanning the first 1100bp upstream of the initiating ATG start codon exhibited high-level activity in HEK-293 cells. Several consensus binding sites for the transcription factor Sp1 as well as a c-Myc binding site were identified in this promoter region. Altogether, these results provide the basis for more detailed studies on the regulation of telomerase activity in normal and cancer cells, and may lead to the development of new cancer therapies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10333526     DOI: 10.1016/s0378-1119(99)00108-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  94 in total

1.  The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity.

Authors:  L M Colgin; C Wilkinson; A Englezou; A Kilian; M O Robinson; R R Reddel
Journal:  Neoplasia       Date:  2000 Sep-Oct       Impact factor: 5.715

Review 2.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

3.  Regulatory mechanisms of human and mouse telomerase reverse transcriptase gene transcription: distinct dependency on c-Myc.

Authors:  Tsukasa Fujiki; Miyako Udono; Keishi Kadooka; Shuntaro Yamashita; Takumi Miura; Sanetaka Shirahata; Yoshinori Katakura
Journal:  Cytotechnology       Date:  2010-05-08       Impact factor: 2.058

4.  Expression of MTLC gene in gastric carcinoma.

Authors:  Guang-Bin Qiu; Li-Guo Gong; Dong-Mei Hao; Zhi-Hong Zhen; Kai-Lai Sun
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

5.  Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing.

Authors:  Dennis Gomez; Thibault Lemarteleur; Laurent Lacroix; Patrick Mailliet; Jean-Louis Mergny; Jean-François Riou
Journal:  Nucleic Acids Res       Date:  2004-01-16       Impact factor: 16.971

6.  Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck.

Authors:  Zhensheng Liu; Guojun Li; Sheng Wei; Jiangong Niu; Li-E Wang; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2010-08-28       Impact factor: 4.944

Review 7.  The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance.

Authors:  Jonathan H Teichroeb; Joohwan Kim; Dean H Betts
Journal:  RNA Biol       Date:  2016-01-19       Impact factor: 4.652

8.  The hTERT and hTERC telomerase gene promoters are activated by the second exon of the adenoviral protein, E1A, identifying the transcriptional corepressor CtBP as a potential repressor of both genes.

Authors:  Rosalind M Glasspool; Sharon Burns; Stacey F Hoare; Catharina Svensson; W Nicol Keith
Journal:  Neoplasia       Date:  2005-06       Impact factor: 5.715

9.  Increased hTR expression during transition from adenoma to carcinoma is not associated with promoter methylation.

Authors:  Atsuo Nakamura; Takeshi Suda; Terasu Honma; Toru Takahashi; Masato Igarashi; Nobuo Waguri; Hirokazu Kawai; Yusaku Mita; Yutaka Aoyagi
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

10.  Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms.

Authors:  Yongchun Wang; Jeanne Kowalski; Hua-Ling Tsai; Radharani Marik; Nijaguna Prasad; Helina Somervell; Pang-Kuo Lo; Lauren E Sangenario; Lars Dyrskjot; Torben F Orntoft; William H Westra; Alan K Meeker; James R Eshleman; Christopher B Umbricht; Martha A Zeiger
Journal:  Thyroid       Date:  2008-10       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.